Michael Allen Flynn

1 Patent

• US121459862024

  Method of Treating an Ocular Condition by Administering a Humanized Monoclonal Antibodies That Target VE-PTP (hptp-beta)

  EYEPOINT PHARMACEUTICALS, Inc.

  0 cites